These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 12798392

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Consideration of molecular weight during compound selection in virtual target-based database screening.
    Pan Y, Huang N, Cho S, MacKerell AD.
    J Chem Inf Comput Sci; 2003; 43(1):267-72. PubMed ID: 12546562
    [Abstract] [Full Text] [Related]

  • 3. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB, Vaidehi N, Zamanakos G, Goddard WA.
    J Med Chem; 2004 Jan 01; 47(1):56-71. PubMed ID: 14695820
    [Abstract] [Full Text] [Related]

  • 4. Recent advances in computer-aided drug design.
    Song CM, Lim SJ, Tong JC.
    Brief Bioinform; 2009 Sep 01; 10(5):579-91. PubMed ID: 19433475
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep 01; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovering potassium channel blockers from synthetic compound database by using structure-based virtual screening in conjunction with electrophysiological assay.
    Liu H, Gao ZB, Yao Z, Zheng S, Li Y, Zhu W, Tan X, Luo X, Shen J, Chen K, Hu GY, Jiang H.
    J Med Chem; 2007 Jan 11; 50(1):83-93. PubMed ID: 17201412
    [Abstract] [Full Text] [Related]

  • 11. Identifying putative drug targets and potential drug leads: starting points for virtual screening and docking.
    Wishart DS.
    Methods Mol Biol; 2008 Jan 11; 443():333-51. PubMed ID: 18446295
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Virtual screening for lead discovery.
    Tang YT, Marshall GR.
    Methods Mol Biol; 2011 Jan 11; 716():1-22. PubMed ID: 21318897
    [Abstract] [Full Text] [Related]

  • 15. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC.
    Curr Opin Drug Discov Devel; 2008 May 11; 11(3):356-64. PubMed ID: 18428089
    [Abstract] [Full Text] [Related]

  • 16. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T, Krovat EM.
    Curr Opin Drug Discov Devel; 2003 May 11; 6(3):370-6. PubMed ID: 12833670
    [Abstract] [Full Text] [Related]

  • 17. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B.
    Drug Discov Today; 2008 Mar 11; 13(5-6):219-26. PubMed ID: 18342797
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Critical assessment of the automated AutoDock as a new docking tool for virtual screening.
    Park H, Lee J, Lee S.
    Proteins; 2006 Nov 15; 65(3):549-54. PubMed ID: 16988956
    [Abstract] [Full Text] [Related]

  • 20. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ, Meegan MJ, Carta G, Lloyd DG.
    J Chem Inf Model; 2005 Nov 15; 45(6):1908-19. PubMed ID: 16309298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.